Towards the development of modulators of LRH-1 as potential anti-cancer therapeutic leads
Breast cancer is the most common cancer in women worldwide and afflicts about 30 % of all women between 35 and 50 years. The majority of breast cancers are estrogen dependent. This means that they need estrogen for their development and growth. Estrogen dependent breast cancers can be treated with h...
Main Author: | Mueller, Melanie |
---|---|
Other Authors: | Spivey, Alan C. |
Published: |
Imperial College London
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.679650 |
Similar Items
-
Towards the synthesis of selective CDK7 inhibitors as potential anti-cancer drugs
by: Kroll, Sebastian Herbert Benjamin
Published: (2011) -
Identification and optimisation of small molecule modulators of Orai3 and TRPC4 as potential therapeutics
by: Hamzah, Nurasyikin Binti
Published: (2018) -
Preparation of LRH-1 Antibody & Regulation of CYP11A1 Gene by LRH-1
by: Chien-Ting Pan, et al.
Published: (2005) -
LRH-1 as a target for the development of new breast cancer therapies
by: Kyle, Fiona
Published: (2014) -
Development of new bis(thiosemicarbazonates) and investigations into their potential as molecular imaging and therapeutic agents
by: Arrowsmith, Rory
Published: (2013)